Predictors for remission in rheumatoid arthritis patients: A systematic review

Arthritis Care and Research - Tập 62 Số 8 - Trang 1128-1143 - 2010
Wanruchada Katchamart1, Sindhu R. Johnson, Hsing-Ju Lucy Lin, Veerapong Phumethum, Carine Salliot, Claire Bombardier
1University of Toronto, Ontario, Canada. [email protected]

Tóm tắt

AbstractObjectiveTo summarize the potential predictors of remission in patients with rheumatoid arthritis (RA).MethodsWe performed a systematic review of prognostic studies that identified the predictors of remission in RA patients. Studies were identified in Medline, EMBase, and the Cochrane Registry, and by hand search. We included only studies performing multivariate analysis.ResultsA total of 18 studies from 2,062 citations were included. The following variables were found to be the independent predictors of RA remission: male sex; young age; late‐onset RA; short disease duration; nonsmoker; low baseline disease activity; mild functional impairment; low baseline radiographic damage; absence of rheumatoid factor and anti–citrullinated peptide; low serum level of acute‐phase reactant, interleukin‐2, and RANKL at baseline; MTHFR 677T alleles and 1298C alleles in the methotrexate (MTX)–treated patients; magnetization transfer ratio 2756A allele ± either the SLC 19A180A allele or the TYMS 3R‐del6 haplotype in the MTX plus sulfasalazine combination–treated patients; early treatment with nonbiologic disease‐modifying antirheumatic drug (DMARD) combinations; the use of anti–tumor necrosis factor (anti‐TNF); the concurrent use of DMARDs in anti‐TNF–treated patients; and moderate or good response to treatments at the first 6 months. The magnitude of the association in the individual predictor was diverse among the studies depending on the patient characteristics, the study characteristics, and the variables used to adjust for in the models.ConclusionA number of independent predictors of remission, i.e., baseline clinical and laboratory characteristics and genetic markers, were summarized. The predictive value of prognostic factors recently identified needs to be confirmed.

Từ khóa


Tài liệu tham khảo

10.1016/j.berh.2004.08.011

10.1136/ard.2004.030924

10.1136/ard.2007.071092

10.1016/S0140-6736(04)16676-2

10.1186/1471-2474-9-52

10.1002/art.1780310302

10.7326/0003-4819-144-6-200603210-00010

10.1093/rheumatology/38.3.228

10.1002/art.10135

10.1136/ard.61.4.351

10.1136/ard.2003.010611

10.1136/ard.2003.014928

Kuuliala A, 2005, Serum soluble interleukin‐2 receptor predicts early remission in patients with recent‐onset rheumatoid arthritis treated with a single disease‐modifying antirheumatic drug, Clin Exp Rheumatol, 23, 243

Vazquez I, 2007, Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting, Clin Exp Rheumatol, 25, 231

10.2217/14622416.8.11.1551

10.1136/ard.2006.056937

James HM, 2008, Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis, J Rheumatol, 35, 562

10.1002/art.21830

10.1093/rheumatology/kel149

10.1002/art.23141

10.1136/ard.2007.071910

10.1093/rheumatology/ken002

10.1002/art.23247

Mancarella L, 2007, Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor‐α blockers: the GISEA study, J Rheumatol, 34, 1670

Liang GC, 2005, Current tumor necrosis factor‐α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis, J Rheumatol, 32, 1662

10.1136/ard.2007.084509

10.1136/ard.2005.041079

10.1002/art.1790090605

Sokka T, 2009, Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST‐RA study, Arthritis Res Ther, 11, R7

10.1136/ard.51.4.473

10.1093/rheumatology/kem051

Aletaha D, 2006, Remission of rheumatoid arthritis: should we care about definitions?, Clin Exp Rheumatol, S45

1993, Outcome measures in rheumatoid arthritis clinical trials, J Rheumatol, 20, 526

10.1002/art.24123

10.1016/j.jclinepi.2007.08.005